| 000 | 01478 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515054659.0 | ||
| 264 | 0 | _c20070808 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a1533-7294 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMuench, John | |
| 245 | 0 | 0 |
_aClinical inquiries. Angiotensin blockade for diabetes: monitor microalbuminuria? _h[electronic resource] |
| 260 |
_bThe Journal of family practice _cFeb 2007 |
||
| 300 |
_a145-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAlbuminuria _xdrug therapy |
| 650 | 0 | 4 | _aAngiotensin II Type 2 Receptor Blockers |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xcomplications |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xetiology |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aFamily Practice |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKidney Function Tests |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMonitoring, Physiologic _xstandards |
| 650 | 0 | 4 |
_aReceptor, Angiotensin, Type 2 _xadministration & dosage |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aUrinalysis |
| 700 | 1 | _aBlenning, Carol | |
| 700 | 1 | _aJudkins, Dolores Zegar | |
| 700 | 1 | _aVincent, Chris | |
| 773 | 0 |
_tThe Journal of family practice _gvol. 56 _gno. 2 _gp. 145-6 |
|
| 999 |
_c16831060 _d16831060 |
||